Source:http://linkedlifedata.com/resource/pubmed/id/11173684
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
Raltitrexed (Tomudex(R)) is a thymine synthetase inhibitor used for first line treatment of metastatic colorectal cancer. Skin reactions were reported in the preclinical trials but have never been documented in clinical practice. We report the first two cases.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0151-9638
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1080-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
[Raltitrexed-induced skin reaction].
|
pubmed:affiliation |
Centre Régional de Lutte contre le Cancer, Val d'Aurelle, 34298 Montpellier Cedex 5.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|